Sumitomo Pharma America Inc - Company Profile
Powered by 
All the sales intelligence you need on Sumitomo Pharma America Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sumitomo Pharma America Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sumitomo Pharma America Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sumitomo Pharma America Inc (SMPA), formerly Sunovion Pharmaceuticals Inc, is a pharmaceutical company that discovers, develops, and commercializes therapeutic products for central nervous system and respiratory disorders and other illnesses. The company’s business agreements, diverse and focused therapeutic portfolio, and focus on R&D activities are its major strengths, even as private ownership restricts its ability to raise funds could be a cause for concern. The company could find ample opportunities from its regulatory approvals, growing incidence of cancer, and strategic contracts and agreements. However, intense competition, stringent regulations, and uncertain R&D outcomes could affect the company’s operational and financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer